AI Tech Solutions develops AI-driven digital tools that enhance productivity and create engaging entertainment experiences. The company focuses on improving operational efficiency for businesses while providing customized support for successful AI project implementation.

BibliU offers a Learning Enablement platform that automates the workflow for digital textbooks and courseware, providing institutions with access to essential learning materials at 30-50% lower costs than traditional methods. This solution ensures that all students have immediate access to required content, enhancing educational equity and improving student outcomes.

Biofidelity has developed molecular biology technologies, Aspyre® and Enspyre®, that enable local and cost-effective genomic analysis for cancer diagnosis and treatment selection. This approach addresses the challenge of limited access to biomarker testing, ensuring more patients receive timely and appropriate targeted therapies.

Brill Power provides a Battery Intelligence Platform that integrates battery management, chemistry-agnostic operating systems, and connected analytics. This platform enhances the longevity, performance, and sustainability of batteries used in electric vehicles and stationary energy storage. The technology aims to replace legacy battery management systems to unlock greater efficiency and lower lifetime costs for energy storage applications.

Caristo Diagnostics utilizes CaRi-Heart® technology to detect hidden inflammation in coronary arteries, enabling early diagnosis of heart diseases, stroke, and diabetes. This platform enhances preventive screening and optimizes treatment planning by providing individualized risk scores based on advanced imaging analysis.

Cove is a co‑living platform that offers fully furnished private rooms in curated Singapore properties, with utilities, high‑speed Wi‑Fi, housekeeping and maintenance bundled into a single monthly price. Users can book instantly online for flexible stay lengths—monthly or nightly—and filter listings by location, budget and amenities, while enjoying community events and shared spaces that foster a sense of belonging.

The startup has developed a fluid-shaping technology that replaces traditional microtiter plates with a microscale system for single-cell cloning, allowing researchers to expose cells to relevant experimental conditions. This technology enables multiple users to conduct simultaneous experiments efficiently, addressing the limitations of current cloning methods.

Develops affordable hyperspectral imaging cameras that capture spectral data at video rates, enabling applications in agriculture, healthcare, remote sensing, and colorimetry. These systems provide detailed insights beyond visible light, improving decision-making by revealing hidden information such as crop health, tissue types, and product appearance under varying lighting conditions.

Moment Technologies develops a software development tool that integrates various control, monitoring, and command-line tools into a single user interface, enabling infrastructure and platform teams to streamline their workflows. The platform facilitates the creation of interactive documentation using Git and Markdown, enhancing developer onboarding and release management while improving collaboration.

Nano Corp provides a deep network observability platform that enables full visibility of hybrid networks by analyzing every packet across all devices, identifying unknown devices and suspicious patterns. Their AI-powered on-premise detection solution enhances threat detection capabilities without sharing metadata, addressing the limitations of traditional EDR and XDR systems.

The startup has developed a peptide identification and optimization platform that utilizes peptide bead display and ribonucleic acid display technologies to discover and present novel natural peptides. This platform enables clients to efficiently identify therapeutic candidates through high-throughput affinity and functional screening, addressing the need for biologically relevant peptide leads in drug development.

Provides a clear aligner system combining FDA-cleared night-only wear NiTime Aligners™ and stain-resistant Bright Aligners™ to straighten and whiten teeth simultaneously. This approach offers a discreet, comfortable, and efficient alternative to traditional braces, treating various orthodontic issues while allowing patients to eat, drink, and speak without restrictions during the day.

Provides portable, lab-quality diagnostic testing through a single, low-cost instrument that integrates microfluidic sample preparation and electrochemical biosensing. This technology enables accurate, multiplexed testing in diverse settings like emergency departments, doctor’s offices, and retail pharmacies, addressing the need for accessible and efficient healthcare diagnostics.

Provides an API-driven authorization service that enables developers to implement role-based (RBAC), relationship-based (ReBAC), and attribute-based (ABAC) access control without overhauling existing application architectures. By generating SQL filters and authorizing locally against existing databases, it reduces integration time, eliminates syncing issues, and supports high-performance, scalable permission management across cloud, hybrid, and on-prem environments.

Ox provides a Human-Centered Automation platform that integrates with existing warehouse systems to create AI-powered workflows, enhancing frontline productivity and reducing training times. By focusing on the operator experience, Ox addresses the challenge of inefficient manual processes in supply chain operations, enabling companies to optimize their workforce and improve operational efficiency.

The startup has developed a brain biomarker technology that utilizes magnetic resonance imaging to measure cortical disarray, providing an index of cellular circuit health in the brain. This technology enables early and differential diagnosis of cognitive diseases, particularly Alzheimer's, allowing for timely intervention and treatment.

Oxford Endovascular is developing OxiFlow™, a next-generation flow diverter that redirects blood flow away from intracranial aneurysms at risk of rupture, enhancing placement accuracy and safety. This technology addresses the critical issue of brain hemorrhage, which affects 1 in 50 individuals, by making more patients eligible for effective treatment.

The startup develops lightweight pressure control equipment, including gas and fluid pressure regulators, to enhance the reliability of conventional valve systems. Their technology simplifies water distribution systems, ensuring consistent potable water supply while meeting stringent water quality and leakage control standards, ultimately reducing operational costs for energy, water, and process industries.

Oxford PV develops perovskite-on-silicon tandem solar cells that significantly increase energy conversion efficiency beyond conventional silicon limits. This technology integrates with existing manufacturing processes to deliver higher power output per area, reducing the levelized cost of energy for solar installations.

Oxford Quantum Circuits develops enterprise-ready quantum computing solutions that utilize hybrid computation to tackle complex problems beyond the capabilities of classical machines. Their technology enables businesses to access quantum capabilities securely and reliably, facilitating breakthroughs in various industries.

Salú provides a digital platform that integrates occupational health and safety management with human resources systems, automating compliance with legal requirements and streamlining health examinations and safety training. By managing over 350 clients and 150,000 lives, Salú enhances workplace well-being and reduces administrative burdens through real-time health data analytics and a network of over 1,200 clinics across Brazil.

SpyBiotech is a clinical-stage biotechnology company utilizing its proprietary protein superglue technology, SpyTag/SpyCatcher, to develop vaccines against infectious diseases and cancer. The company focuses on creating effective vaccines for conditions like cytomegalovirus, which currently lacks adequate prevention and treatment options.

TakeIt.co provides a secure platform for buying and leasing domain names, ensuring safe transactions and fast transfers through streamlined processes. The service addresses the complexities and risks associated with domain acquisition, making it easier for users to navigate the marketplace.

T-Cypher Bio develops T-cell receptor-based therapeutics that utilize proprietary target screening libraries to identify functionally defined T-cell clones from disease tissues, specifically for solid tumors and other immune-mediated diseases. This approach enables healthcare providers to create tailored cell therapies that address the limitations of existing cancer treatments by targeting a broader range of tumor-specific antigens.